INNATE PHARMA SA-SPONS ADR
IPHANASDAQ🏆 #3142 by market capEarnings Sep 17US Equity
$2.15▼ $0.07 (−3.15%)
🌅 Pre-market$2.40▲ 11.67%Regular close · extended-hours price shown1h—
24h▼ 3.1%
7d▲ 22.9%
14d▲ 23.6%
30d▲ 19.4%
1y▼ 1.1%
🏦Market Cap
$202M
Small Cap
📈Revenue Growth (YoY)
-64.7%
Declining
📊Gross Margin
0.8%
Thin
💵FCF Margin
61.8%
Strong
⚖️P/S Ratio
31.8x
Expensive
Otter Score
47
Weak
📊
Analyst Ratings
Price
$2.15
Total
6
Raised
0
Lowered
1
Avg PT
$5.50
H / L
$7 / $4
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-04-07 |
BTIG | Reiterated | Buy | 2025-10-29 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-09-18 |
SVB Leerink | Reiterated | Outperform | 2022-11-15 |
Citigroup | Reiterated | Buy | 2022-09-16 |
Goldman Sachs | Reiterated | Neutral | 2020-11-24 |
One row per institution, most recent rating